Cargando…
P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428975/ http://dx.doi.org/10.1097/01.HS9.0000969404.19790.4a |
| _version_ | 1785090599955726336 |
|---|---|
| author | Byrd, John C. Ali Bhat, Seema Awan, Farrukh Giri, Pratyush Ratnasingam, Sumita Hájek, Roman Hess, Dagmar Alves, Daniela Maciej Zaucha, Jan Shen, Annalise Bilotti, Elizabeth Mcgreivy, Jesse P. Rothbaum, Wayne Ciepluch, Hanna |
| author_facet | Byrd, John C. Ali Bhat, Seema Awan, Farrukh Giri, Pratyush Ratnasingam, Sumita Hájek, Roman Hess, Dagmar Alves, Daniela Maciej Zaucha, Jan Shen, Annalise Bilotti, Elizabeth Mcgreivy, Jesse P. Rothbaum, Wayne Ciepluch, Hanna |
| author_sort | Byrd, John C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428975 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104289752023-08-17 P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) Byrd, John C. Ali Bhat, Seema Awan, Farrukh Giri, Pratyush Ratnasingam, Sumita Hájek, Roman Hess, Dagmar Alves, Daniela Maciej Zaucha, Jan Shen, Annalise Bilotti, Elizabeth Mcgreivy, Jesse P. Rothbaum, Wayne Ciepluch, Hanna Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428975/ http://dx.doi.org/10.1097/01.HS9.0000969404.19790.4a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Byrd, John C. Ali Bhat, Seema Awan, Farrukh Giri, Pratyush Ratnasingam, Sumita Hájek, Roman Hess, Dagmar Alves, Daniela Maciej Zaucha, Jan Shen, Annalise Bilotti, Elizabeth Mcgreivy, Jesse P. Rothbaum, Wayne Ciepluch, Hanna P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title | P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title_full | P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title_fullStr | P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title_full_unstemmed | P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title_short | P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) |
| title_sort | p625: a phase 1b/2 study of navtemadlin combined with acalabrutinib in btk inhibitor naïve patients with relapsed/refractory (r/r) chronic lymphocytic leukemia (cll) or small lymphocytic lymphoma (sll) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428975/ http://dx.doi.org/10.1097/01.HS9.0000969404.19790.4a |
| work_keys_str_mv | AT byrdjohnc p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT alibhatseema p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT awanfarrukh p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT giripratyush p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT ratnasingamsumita p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT hajekroman p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT hessdagmar p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT alvesdaniela p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT maciejzauchajan p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT shenannalise p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT bilottielizabeth p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT mcgreivyjesse p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT prothbaumwayne p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll AT ciepluchhanna p625aphase1b2studyofnavtemadlincombinedwithacalabrutinibinbtkinhibitornaivepatientswithrelapsedrefractoryrrchroniclymphocyticleukemiacllorsmalllymphocyticlymphomasll |